BridgeMD
New treatment option for Oral Cancer
Official title Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC
ClinicalTrials.gov ID: NCT06623266
What this study is testing
- What it's testing
- To evaluate the clinical outcomes of 2-year lymph node metastasis rate, disease-free survival, overall survival, and health-related quality of life in the patients with cT1N0M0 oral squamous cell carcinoma, who receive primary lesion resection combined with elective neck dissection or primary lesion resection only.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Tumor site: tongue, gingiva, buccal mucosa, floor of mouth, hard palate, retromolar eara
- Clinical stage is cT1N0M0 (AJCC 8th edition)
- Pathological diagnosis of squamous cell carcinoma
- Sign the informed consent form
You likely can't join if
- More than 2 lesions found in the oral cavity
- Known history of malignant tumor within five years (unless the patient has undergone curative treatment and there is no disease recurrence within 5...
- History of unilateral or bilateral neck dissection in the past
- History of previous head and neck radiotherapy
- Pregnant or lactating women
- Severe, uncontrolled infection or known HIV infection; or previous organ transplantation, stem cell or bone marrow transplantation
See the full eligibility criteria
- Tumor site: tongue, gingiva, buccal mucosa, floor of mouth, hard palate, retromolar eara
- Clinical stage is cT1N0M0 (AJCC 8th edition)
- Pathological diagnosis of squamous cell carcinoma
- Sign the informed consent form
- More than 2 lesions found in the oral cavity
- Known history of malignant tumor within five years (unless the patient has undergone curative treatment and there is no disease recurrence within 5 years since the start of treatment)
- History of unilateral or bilateral neck dissection in the past
- History of previous head and neck radiotherapy
- Pregnant or lactating women
- Severe, uncontrolled infection or known HIV infection; or previous organ transplantation, stem cell or bone marrow transplantation
- Participated in other clinical studies within 30 days before enrollment
- Other circumstances that the researcher considers unsuitable for participation in the study
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.